Ibrance 125 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26F9FAD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,555
Award facts
- Contract value 100% obligated
- $8,555.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 13, 2026, with a ceiling value of $8,555.21 for the supply of Ibrance 125 mg capsule 21s.
Place of performance is Conshohocken, PA. The order is firm fixed price and has an ultimate completion date of March 9, 2026.
Quick answers
Who was awarded contract SPE2DR26F9FAD?
SPE2DR26F9FAD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 13, 2026.
How much is contract SPE2DR26F9FAD worth?
The government has obligated $8,555 on SPE2DR26F9FAD.
Is contract SPE2DR26F9FAD an order under another contract?
Yes. SPE2DR26F9FAD is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9FAD competed?
The extent of competition for SPE2DR26F9FAD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award